71) and labetalol (RR 0
In the event of hypertensive emergency, nifedipine, labetalol, and hydralazine are assigned as first-line therapies in preeclampsia
This study was a double-blind, randomized clinical trial to compare the effectiveness of oral nifedipine, intravenous labetalol, and intravenous hydralazine as
Recently Labetalol was introduced in the obstetrics unit, of the University of Abuja Teaching Hospital but hydralazine has been in use for the management of severe pre-eclampsia
This study showed that both hydralazine and labetalol are effective in lowering blood pressure in pregnant women with severe hypertension
A severe increase in blood pressure can lead to preeclampsia, eclampsia, cerebrovascular hemorrhage, and hypertensive encephalopathy, all of which are
Acute severe pre-eclampsia requires urgent antihypertensive therapy to reduce the incidence of adverse outcome [Citation 8]
Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy
1 days (mean±SD) for Background: Authors sought to compare the effectively of intravenous hydralazine and intravenous labetalol in controlling acute rise in blood pressure in patients with severe preeclampsia
PLoS One
1mg of hydralazine per ml) Give 250 ml of crystalloid IV with first dose (if patient hasn’t had fluids already) Check BP every 5 minutes after bolus dose
84–3
Hyperaldosteronism
3 for labetalol, P<0
The aim of this expert panel guidelines is to evaluate the impact of different aspects of the management of women with severe preeclampsia on maternal and neonatal morbidities
A comparative study of IV labetalol and IV hydralazine on mean arterial blood pressure changes in pregnant women with hypertensive emergency
A randomized, controlled trial
(MgSO4) for the Prevention of Eclampsia Trial and the Antihypertensive Treatment in Stable Pregnant Women with Severe Preeclampsia